Elsevier

Preventive Medicine

Volume 20, Issue 1, January 1991, Pages 47-63
Preventive Medicine

Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence,☆☆

https://doi.org/10.1016/0091-7435(91)90006-PGet rights and content

Abstract

Considerable epidemiological evidence has accumulated regarding the effect of postmenopausal estrogens on coronary heart disease risk. Five hospital-based case-control studies yielded inconsistent but generally null results; however, these are difficult to interpret due to the problems in selecting appropriate controls. Six population-based case-control studies found decreased relative risks among estrogen users, though only 1 was statistically significant. Three cross-sectional studies of women with or without stenosis on coronary angiography each showed markedly less atherosclerosis among estrogen users. Of 16 prospective studies, 15 found decreased relative risks, in most instances, statistically significant. The Framingham study alone observed an elevated risk, which was not statistically significant when angina was omitted. A reanalysis of the data showed a nonsignificant protective effect among younger women and a nonsignificant increase in risk among older women. Overall, the bulk of the evidence strongly supports a protective effect of estrogens that is unlikely to be explained by confounding factors. This benefit is consistent with the effect of estrogens on lipoprotein subfractions (decreasing low-density lipoprotein levels and elevating high-density lipoprotein levels). A quantitative overview of all studies taken together yielded a relative risk of 0.56 (95% confidence interval 0.50–0.61), and taking only the internally controlled prospective and angiographic studies, the relative risk was 0.50 (95% confidence interval 0.43–0.56).

References (41)

  • U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Health Statistics

    Vital statistics of the United States 1986. Volume II—Mortality

    (1988)
  • GA Colditz et al.

    Menopause and the risk of coronary heart disease in women

    N Engl J Med

    (1987)
  • MJ Stampfer et al.

    Menopause and heart disease: A review

    Ann NY Academy Sci

    (1990)
  • S Greenland

    Quantitative methods in the review of epidemiologic literature

    Epidemiol Rev

    (1987)
  • L Rosenberg et al.

    Myocardial infarction and estrogen therapy in postmenopausal women

    N Engl J Med

    (1976)
  • H Jick et al.

    Noncontraceptive estrogens and nonfatal myocardial infarction

    JAMA

    (1978)
  • L Rosenberg et al.

    Noncontraceptive estrogens and myocardial infarction in young women

    JAMA

    (1980)
  • H Jick et al.

    Myocardial infarction and other vascular diseases in young women: Role of estrogens and other factors

    JAMA

    (1978)
  • C La Vecchia et al.

    Risk factors for myocardial infarction in young women

    Am J Epidemiol

    (1987)
  • RI Pfeffer et al.

    Coronary risk and estrogen use in post-menopausal women

    Am J Epidemiol

    (1978)
  • Cited by (0)

    Supported by Research Grants CA 40935 and HL 35464 from the National Institutes of Health.

    ☆☆

    Presented at the Workshop on Antiestrogen Prevention of Breast Cancer, October 2–3, 1989, Madison, WI. Proceedings cosponsored by the National Cancer Institute (Grant 1 R13 CA49561-01) and the American Cancer Society (Grant RD 291).

    View full text